Biagio Ricciuti, MD PhD
@BiagioRicciutMD
Thoracic Medical Oncologist at @DanaFarber | @harvardmed | #Immunotherapy #KRAS #LungCancer
16-01-2019 19:33:58
403 Tweets
1,0K Followers
362 Following
Great overview of resistance mechanisms to #KRAS inhibitors in #NSCLC at #RomeLung24 by AmbrogioLab. Different therapeutic vulnerabilities depending on whether resistance is intrinsic, acquired, or adaptive.
